Oliver Treeck

Professor (Associate) Dr. rer. nat. (PhD), Research Group Leader "Molecular Gynecologic Oncology"

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Oliver Treeck, Dr. rer. nat., is an Associate Professor and Research Group Leader in "Molecular Gynecologic Oncology" at Universitätsklinikum Regensburg, Germany. His research focuses on estrogen receptor signaling and its implications in gynecologic cancers, particularly ovarian and breast cancer. Recent publications include studies on epigenetic modulation, endocrine interventions, and the role of non-coding RNAs in cancer therapy and risk assessment.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (4)

Silke Haerteis

University of Regensburg

GERMANY

View details

Carsten Gründker

University Medical Center Göttingen

GERMANY

View details

Florian Weber

University of Regensburg

GERMANY

View details

Christa Buechler

University Hospital Regensburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oliver Treeck

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Effects of Endocrine Interventions Targeting ERα or PR on Breast Cancer Risk in the General Population and Carriers of BRCA1/2 Pathogenic Variants

Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer

Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy

Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer

Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer

Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling

Chemerin and Chemokine-like Receptor 1 Expression Are Associated with Hepatocellular Carcinoma Progression in European Patients

The Complex Roles of Adipokines in Polycystic Ovary Syndrome and Endometriosis

Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response

DSCAM-AS1 Long Non-Coding RNA Exerts Oncogenic Functions in Endometrial Adenocarcinoma via Activation of a Tumor-Promoting Transcriptome Profile

Expression of estrogen-related receptors in ovarian cancer and impact on survival

Icb-1 expression inhibits growth and fulvestrant response of breast cancer cells and affects survival of breast cancer patients

Collaborators (4)

Silke Haerteis

Carsten Gründker

Florian Weber

Christa Buechler

Make your next move.